Replies to post #316990 on Anavex Life Sciences Corp (AVXL)

[sokol]

Biogen has big competition.

[nidan7500]

Eli Lilly (LLY) – The drugmaker’s shares surged 8.7% in the premarket after Lilly’s Alzheimer’s treatment received “breakthrough therapy” designation from the Food and Drug Administration. The designation means the treatment may show substantial improvement over existing therapies and qualifying it for expedited development and approval.

PATHETIC ....obvious political, media diversion from previous non solution by BIIB.

So, this drug has been shown to reduce the rate of cognition loss at a slightly higher rate than the claimed rate of loss by BIIB. OK, but how the fxxk does that warrant a declaration of ..."BREAKTHROUGH"???? I decode this as clear message of DESPARATION by by FDA....really sad, if this is science then I am "Captain Marvel".

What is it about causal relation they are not getting?